Tag: manufacturing

The electronic-grade sulfuric acid market is projected to grow at a 6.60% CAGR from 2025-2030 due to increased semiconductor demand. With 96% purity, it cleans and etches wafer chips, vital for semiconductor industry growth. Major regions include Asia-Pacific and the Americas, with key players like BASF and Thermo Fisher Scientific. The report offers valuable insights for businesses on market trends, competitive landscapes, and growth opportunities across various sectors like automotive and healthcare.

Medical Opinion Concludes that Beyond Oil has Potential to Reduce Gastrointestinal Cancer Risk Among Consumers of Fried Foods and Food Service Workers

CAMBRIDGE, Mass., June 18, 2025 (GLOBE NEWSWIRE) --  Biogen Inc. (Nasdaq: BIIB) announced the initiation of dosing in the BRAVE study, a global Phase 3 clinical trial. The BRAVE study will evaluate the efficacy and safety of omaveloxolone in children with Friedreich ataxia (FA) between the ages of 2 to <16. Both non-ambulatory and ambulatory participants may qualify for the study. Participants will be randomized 2:1 to receive omaveloxolone or placebo once a day for 52 weeks before having the opportunity to move into the open-label extension (OLE). Currently, omaveloxolone is commercialized under the brand name SKYCLARYS^® in over 40 countries, including in the U.S. and the European Union, and is the only approved product for FA in adults and adolescents aged 16 years and older.